Brain 17 Vienna

Previous Page

Next Page

Page Background

Engagement of CTLA-4 or PD-1 inhibits T cell activity

=> Inhibition of these «checkpoint» molecules may

boost immune reponses against a tumor

Nivolumab

Pembrolizumab

Ipilimumab

Function of CTLA-4 and PD-1